Now, the investigators carried out a prospective study enrolling patients with thyroid cancer, who had received ablative thyroidectomy and /or radioactive iodine therapy for two more years. The investigators' study already enrolled seventy-three patients with thyroid cancer, and the investigators plan to enroll 30 new patients in this consecutive research study. All patients received total thyroidectomy under clinically surgical judgement in initial therapeutic option. The investigators also further found some difference between papillary thyroid cancer and follicular thyroid cancer, and the investigators will continue annually to closely monitor the change of U-Ex Tg and urinary exosomal galectin-3 between differently cellular types of thyroid cancers.
Age range
20 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change of serum thyroglobulin level
Timeframe: Within 36 months
Change of serum free T4 level
Timeframe: Within 36 months
Change of serum TSH level
Timeframe: Within 36 months
Change of anti-thyroglobulin level
Timeframe: Within 36 months
Urinary exosomal thyroglobulin detection
Timeframe: Within 36 months
Urinary exosomal galectin-3 detection
Timeframe: Within 36 months
Urinary exosomal calprotectin A9 detection
Timeframe: Within 36 months
Urinary exosomal transketolase detection
Timeframe: Within 36 months
Urinary exosomal keratin 19 detection
Timeframe: Within 36 months
Urinary exosomal angiopoietin-1 detection
Timeframe: Within 36 months
Urinary exosomal tissue inhibitor of metalloproteinase detection
Timeframe: Within 36 months
Urinary exosomal keratin 8 detection
Timeframe: Within 36 months
Urinary exosomal calprotectin A8 detection
Timeframe: Within 36 months
Urinary exosomal annexin II detection
Timeframe: Within 36 months
Urinary exosomal afamin detection
Timeframe: Within 36 months